Pharmacotherapy of Generalized Anxiety Disorder With Seroquel: Normalization of Brain Stress and Reward Function.

Trial Profile

Pharmacotherapy of Generalized Anxiety Disorder With Seroquel: Normalization of Brain Stress and Reward Function.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 May 2017

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Acronyms GAD
  • Most Recent Events

    • 01 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 17 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top